Hyderabad Strengthens Position as Global Biotech Hub with ₹1,200-Crore Biologics Facility

Hyderabad is advancing its credentials as a global biotechnology and advanced medical research destination with the inauguration of a ₹1,200-crore biologics manufacturing complex. Information Technology and Industries Minister D. Sridhar Babu inaugurated the Theranym Biologics facility at Borpatla village in Hatnoora mandal of Sangareddy district on Wednesday, marking a significant step in the state's life sciences ambitions.
The Telangana government is actively working to establish comprehensive infrastructure that spans the entire spectrum of the life sciences value chain, encompassing research and development through to large-scale commercial manufacturing. The vision extends to positioning Hyderabad as a hub for biologics, vaccines, cell and gene therapies, alongside treatments targeting cancer and rare diseases.
While Hyderabad has already secured recognition as India's pharmaceutical capital, Sridhar Babu emphasised the state's determination to elevate its standing as a world-class biotechnology destination. The government is strategically preparing to harness emerging technologies—including artificial intelligence, robotics, and advanced genetics—that are expected to reshape the biotechnology landscape in the coming years.
To realise this vision, the state is implementing several flagship initiatives. These include the Life Sciences Policy, One Bio Hub, Green Pharma City, and the Life Sciences Hub, all designed to strengthen the global reach of Telangana's life sciences sector and reinforce the "Made in Telangana" brand.
The minister underscored the critical importance of human capital development, stressing that the state is investing in world-class infrastructure alongside cultivating industry-ready talent. He called upon pharmaceutical and biotechnology enterprises to partner with the government on skill development and workforce training programmes.
The Theranym Biologics facility represents a milestone in Telangana's transformation into a global life sciences hub. The manufacturing complex will produce advanced therapeutics for cancer and other serious illnesses, with plans to export these products to markets including the United States. The project is anticipated to generate employment opportunities for more than 1,500 individuals.
Sridhar Babu reaffirmed the government's commitment to backing industrial investments and fostering innovation-led economic growth. Health Minister Damodar Rajanarsimha, TGIIC Chairperson Nirmala Jagga Reddy, and Theranym Biologics representatives participated in the inauguration ceremony.
Compare options


